Dr Russell N Beckhardt, MD - Medicare Otolaryngology in Astoria, NY

Dr Russell N Beckhardt, MD is a medicare enrolled "Otolaryngology" physician in Astoria, New York. He went to Icahn School Of Medicine At Mount Sinai and graduated in 1988 and has 36 years of diverse experience with area of expertise as Otolaryngology. He is a member of the group practice Ent And Allergy Associates Llp and his current practice location is 3119 Newtown Ave, Suite 201, Astoria, New York. You can reach out to his office (for appointments etc.) via phone at (718) 971-2489.

Dr Russell N Beckhardt is licensed to practice in New York (license number 179767) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1770541120.

Contact Information

Dr Russell N Beckhardt, MD
3119 Newtown Ave, Suite 201,
Astoria, NY 11102-1350
(718) 971-2489
(718) 971-2489



Physician's Profile

Full NameDr Russell N Beckhardt
GenderMale
SpecialityOtolaryngology
Experience36 Years
Location3119 Newtown Ave, Astoria, New York
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Russell N Beckhardt attended and graduated from Icahn School Of Medicine At Mount Sinai in 1988
  NPI Data:
  • NPI Number: 1770541120
  • Provider Enumeration Date: 05/03/2006
  • Last Update Date: 04/02/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 1355429259
  • Enrollment ID: I20080417000287

Medical Identifiers

Medical identifiers for Dr Russell N Beckhardt such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1770541120NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Y00000XOtolaryngology 179767 (New York)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
New York University Langone Medical CenterNew york, NYHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Ent And Allergy Associates Llp0749193662368

News Archive

3 new genes in genetic research of suicidal behaviour

Three genes that have barely been studied to date have now provided fresh knowledge about patients with suicidal backgrounds. This is the result of a study by a team of Spanish researchers at Mount Sinai Hospital and Columbia University in the City of New York (United States), which found that several mutations are involved. This finding could help to develop future genetic tests to identify predisposition to suicide, without ignoring the importance of social and cultural factors.

BCAN holds regional Bladder Cancer Patient Forum at New York Academy of Medicine

Bladder cancer is the fifth most commonly diagnosed cancer in the United States, yet most people know nothing about it. To help enhance the public's understanding of the risks and signs of bladder cancer and the importance of early detection and treatment options, the Bladder Cancer Advocacy Network (BCAN) will hold its regional Bladder Cancer Patient Forum "Understanding Bladder Cancer" on Saturday, October 23, 2010, in New York City at the New York Academy of Medicine.

Yale School of Medicine expands research using transcranial magnetic stimulation for schizophrenia

Yale School of Medicine researchers are recruiting patients nationally for a clinical trial using transcranial magnetic stimulation (TMS) to help still the voices that are so troubling to some persons with schizophrenia.

Use of combined PET/CT can confirm suspected colorectal cancer recurrence at early stage: Study

The use of combined positron emission tomography and computed tomography can confirm a suspected colorectal cancer recurrence at an early stage, helping significantly in treatment planning and improved targeted patient care, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.

Allogeneic transplants via Blood/Marrow Transplant Program show better outcomes

For the fourth consecutive year, outcomes for patients receiving allogeneic transplants through the Blood and Marrow Transplant Program at Roswell Park Cancer Institute (RPCI) have been shown to be significantly better than would be expected among the patient population treated.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Russell N Beckhardt allows following entities to bill medicare on his behalf.
Entity NameEnt And Allergy Associates Llp
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1376598326
PECOS PAC ID: 0749193662
Enrollment ID: O20031107000043

News Archive

3 new genes in genetic research of suicidal behaviour

Three genes that have barely been studied to date have now provided fresh knowledge about patients with suicidal backgrounds. This is the result of a study by a team of Spanish researchers at Mount Sinai Hospital and Columbia University in the City of New York (United States), which found that several mutations are involved. This finding could help to develop future genetic tests to identify predisposition to suicide, without ignoring the importance of social and cultural factors.

BCAN holds regional Bladder Cancer Patient Forum at New York Academy of Medicine

Bladder cancer is the fifth most commonly diagnosed cancer in the United States, yet most people know nothing about it. To help enhance the public's understanding of the risks and signs of bladder cancer and the importance of early detection and treatment options, the Bladder Cancer Advocacy Network (BCAN) will hold its regional Bladder Cancer Patient Forum "Understanding Bladder Cancer" on Saturday, October 23, 2010, in New York City at the New York Academy of Medicine.

Yale School of Medicine expands research using transcranial magnetic stimulation for schizophrenia

Yale School of Medicine researchers are recruiting patients nationally for a clinical trial using transcranial magnetic stimulation (TMS) to help still the voices that are so troubling to some persons with schizophrenia.

Use of combined PET/CT can confirm suspected colorectal cancer recurrence at early stage: Study

The use of combined positron emission tomography and computed tomography can confirm a suspected colorectal cancer recurrence at an early stage, helping significantly in treatment planning and improved targeted patient care, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.

Allogeneic transplants via Blood/Marrow Transplant Program show better outcomes

For the fourth consecutive year, outcomes for patients receiving allogeneic transplants through the Blood and Marrow Transplant Program at Roswell Park Cancer Institute (RPCI) have been shown to be significantly better than would be expected among the patient population treated.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Russell N Beckhardt is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Russell N Beckhardt, MD
660 White Plains Rd Fl 4,
Tarrytown, NY 10591-5139

Ph: (914) 984-2546
Dr Russell N Beckhardt, MD
3119 Newtown Ave, Suite 201,
Astoria, NY 11102-1350

Ph: (718) 971-2489

News Archive

3 new genes in genetic research of suicidal behaviour

Three genes that have barely been studied to date have now provided fresh knowledge about patients with suicidal backgrounds. This is the result of a study by a team of Spanish researchers at Mount Sinai Hospital and Columbia University in the City of New York (United States), which found that several mutations are involved. This finding could help to develop future genetic tests to identify predisposition to suicide, without ignoring the importance of social and cultural factors.

BCAN holds regional Bladder Cancer Patient Forum at New York Academy of Medicine

Bladder cancer is the fifth most commonly diagnosed cancer in the United States, yet most people know nothing about it. To help enhance the public's understanding of the risks and signs of bladder cancer and the importance of early detection and treatment options, the Bladder Cancer Advocacy Network (BCAN) will hold its regional Bladder Cancer Patient Forum "Understanding Bladder Cancer" on Saturday, October 23, 2010, in New York City at the New York Academy of Medicine.

Yale School of Medicine expands research using transcranial magnetic stimulation for schizophrenia

Yale School of Medicine researchers are recruiting patients nationally for a clinical trial using transcranial magnetic stimulation (TMS) to help still the voices that are so troubling to some persons with schizophrenia.

Use of combined PET/CT can confirm suspected colorectal cancer recurrence at early stage: Study

The use of combined positron emission tomography and computed tomography can confirm a suspected colorectal cancer recurrence at an early stage, helping significantly in treatment planning and improved targeted patient care, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.

Allogeneic transplants via Blood/Marrow Transplant Program show better outcomes

For the fourth consecutive year, outcomes for patients receiving allogeneic transplants through the Blood and Marrow Transplant Program at Roswell Park Cancer Institute (RPCI) have been shown to be significantly better than would be expected among the patient population treated.

Read more News

› Verified 1 days ago


Otolaryngology Doctors in Astoria, NY

Mr. Robert E Molle, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 3066 35th St, Astoria, NY 11103
Phone: 718-278-1919    Fax: 718-278-7516
Sabina Omerhodzic, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 3016 30th Dr, Astoria, NY 11102
Phone: 718-626-0707    
Ankit Kansal, M.D.
Otolaryngology
Medicare: Medicare Enrolled
Practice Location: 3119 Newtown Ave Ste 201, Astoria, NY 11102
Phone: 718-971-2490    
Andres Lopez-albaitero, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 3119 Newtown Ave Ste 201, Astoria, NY 11102
Phone: 718-971-2490    Fax: 718-971-2489
Dr. Steven Craig Alexander, M.D.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 3501 30th Ave, Astoria, NY 11103
Phone: 718-726-7000    Fax: 718-726-7110

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.